Abstract

Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility

Author(s): Summers Amy

Issue: Mar/Apr 2023 - Volume 27, Number 2

Page(s): 114-121

Download in electronic PDF format for $75
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 1
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 2
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 3
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 4
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 5
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 6
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 7
  • Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Page 8

Abstract

Per United States Pharmacopeia Chapter <797>, effective November 1, 2023, uncovering non-conforming cleanroom microbiological conditions must be investigated thoroughly and in a timely manner. This article’s objective is to outline the basic elements in investigating microbiological excursions at a sterile compounding facility, which models the use of an Ishakawa diagram to conduct a root cause investigation and discusses important concepts such as: product impact analysis, corrective and preventive action effectiveness checks, trend analysis, and investigational pitfalls to avoid. While this article focuses on investigating microbiological excursions, the concepts can be applied to investigating an out-of-range temperature, relative humidity, pressure differential, total particle count, or compounded sterile preparation failure.

Related Keywords

  • microbiological excursions
  • sterile compounding facilities
  • United States Pharmacopeia Chapter <797>
  • USP
  • cleanroom
  • Ishakawa diagram
  • environmental investigations
  • investigative methods
  • root cause investigations
  • compounding personnel
  • cleanroom processes
  • cleanroom equipment
  • engineering controls
  • cleanroom materials and supplies
  • microorganism identification
  • aseptic technique
  • compounded sterile preparations
  • environment
  • product impact analysis
  • corrective and preventive actions
  • CAPA plan effectiveness checks
  • remediation
  • investigation pitfalls

Related Categories

  • ENVIRONMENTAL
  • STERILE PREPARATIONS
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • INFORMATION RESOURCES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2023
Pg. 114-121
Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility
Author(s): Summers Amy
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 234-238
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007
Pg. 302-305
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Okeke Claudia C
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Sep/Oct 2007
Pg. 404-410
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2017
Pg. 182-190
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Author(s): Ligugnana Roberto
Sep/Oct 2008
Pg. 440-443
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2004
Pg. 251-263
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Author(s): Newton David W, Trissel Lawrence A
Jan/Feb 2023
Pg. 39-46
Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Author(s): Summers Amy, Stephens Pat
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Jan/Feb 2012
Pg. 6-10
Misinterpretation of United States Pharmacopeia Chapter <797>
Author(s): McElhiney Linda F
Jul/Aug 2009
Pg. 322-329
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Author(s): Okeke Claudia C, Allen Loyd V Jr
Mar/Apr 2005
Pg. 127-130
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Newton David W
Jul/Aug 2013
Pg. 283-288
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Author(s): Newton David W
May/Jun 2017
Pg. 193-203
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Author(s): Mixon William, Roth Abby
Jul/Aug 2008
Pg. 344-353
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Author(s): Allen Loyd V Jr, Okeke Claudia C